The safety of diclofenac for the management and treatment of actinic keratoses

Fariba Iraji Isfahan University of Medical Sciences, AlZahra Hospital, Skin Diseases and Leishmaniasis Research Center, Dermatology Department, Isfahan, Iran +98 913 108 9153; +98 311 6684510; [email protected]

Amir Hossein Siadat Isfahan University of Medical Sciences, AlZahra Hospital, Skin Diseases and Leishmaniasis Research Center, Dermatology Department, Isfahan, Iran +98 913 108 9153; +98 311 6684510; [email protected]

Ali Asilian Isfahan University of Medical Sciences, AlZahra Hospital, Skin Diseases and Leishmaniasis Research Center, Dermatology Department, Isfahan, Iran +98 913 108 9153; +98 311 6684510; [email protected]

Shahla Enshaieh Isfahan University of Medical Sciences, AlZahra Hospital, Skin Diseases and Leishmaniasis Research Center, Dermatology Department, Isfahan, Iran +98 913 108 9153; +98 311 6684510; [email protected]

Zabiholah Shahmoradi Isfahan University of Medical Sciences, AlZahra Hospital, Skin Diseases and Leishmaniasis Research Center, Dermatology Department, Isfahan, Iran +98 913 108 9153; +98 311 6684510; [email protected]

Abstract

Background: Actinic keratoses (AKs), defined as carcinoma in situ of squamous carcinoma, is usually induced by excessive sun exposure. The efficacy of 3% diclofenac in 2.5% hyaluronic acid gel for treatment of AKs has been documented in a few studies. Objective: Is diclofenac safe and effective for the management and treatment of AKs? Method: All the papers that were cited in Medline and ISI Web of Science are included in this study. Results/conclusion: The use of diclofenac is associated with a few side effects, which include pruritus, rashes, dry skin, and scaling. These side effects are usually minimal and tolerable; therefore, this topical medication is suggested as the first line of treatment for AKs.

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The safety of diclofenac for the management and treatment of actinic keratoses

Information for

Open access

Opportunities

Help and information

The safety of diclofenac for the management and treatment of actinic keratoses

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature